Business news – Page 103
-
Business
UK nuclear fuel site faces 2018 closure
The Thermal Oxide Reprocessing Plant (Thorp) at Sellafield in the UK will close in 2018
-
OpinionPeace, love and understanding
Chemists and biologists often view the process of drug discovery very differently
-
Business
Takeda buys into Brazil for 540m reals
Multilab makes generics and over-the-counter branded products
-
Business
Solvay opens 200 employee Indian R&D centre
Belgian chemical company opens centre in Savli, Gujarat State
-
BusinessHDL drug class struggling after latest flop
The failure of another ‘good’ cholesterol-raising drug and a new genetic study casts shadow over HDL hypothesis
-
BusinessDrug watchdogs mark out global territory
US and European regulatory agencies are leading worldwide collaborations to ensure drugs from outside their borders are safe
-
News
Pharma firms see mixed fortunes in Quebec
Canada’s pharmaceutical and life sciences hub hit by cutbacks as effects of global slowdown continue to be felt
-
Business
Business roundup: May 2012
Pharmaceutical New cholesterol drugs on the horizon The new candidate reduced "bad" LDL cholesterol by 40-72% in the trial Sanofi has reported Phase II data for a new drug candidate for lowering cholesterol levels in patients already taking statins. Over an 8-12 week period, the candidate reduced ...
-
BusinessAstraZeneca seeks to refill dry pipeline with gout drug
UK pharma giant splashes out $1.26 billion on US gout specialist Ardea Biosciences
-
Business
Dow partners with Oz university
Dow is to partner with the University of Queensland in Australia
-
Business
Seroquel patent row continues
The legal tug of war over the right to sell generic versions of Seroquel (quetiapine) tablets continues
-
Business
Half of sun products have BASF UV filters
German chemical giant BASF says that 50% of all ‘sun care’ products sold today contain its organic UV-A filters
-
Business
US approves new anaemia drug
US authorities have approved Omontys (peginesatide) injections for treating anaemia in dialysis patients with chronic kidney disease
-
Business
Business roundup: April 2012
Pharmaceutical A pill to keep you off the pints? Source: © IStockphoto Beer today, gone tomorrow - Selincro tablets might help patients put their alcohol problems behind them Phase III trials of Selincro (nalmefene) tablets show that it outperforms placebo treatment when used to help patients with ...
-
Business
Light materials from Bayer
Bayer has launched a lightweight material designed to replace steel in railway locomotive and carriage construction
-
Business
PCSK9 inhibitors against cholesterol problems perform well
Sanofi has reported Phase II data for a new drug candidate for lowering cholesterol levels in patients already taking statins
-
Business
$500m for Ista
US eye drug company Bausch & Lomb has signed a cash deal to buy US drugmaker Ista Pharmaceuticals for $9.10 per share, equivalent to $500 million